1. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko, Reiber GE, Bennet PH, editors. Diabetes in America. Washington, DC: U.S. Government Printing Office; 1995. p. 233–57, Chap 11, DHHS NIH Publ no. 95-1468.
2. Portuese E, Orchard T. Mortality in insulin-dependent diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko, Reiber GE, Bennet PH, editors. Diabetes in America. Washington, DC: U.S. Government Printing Office; 1995. p. 221–32, Chap 10, DHHS NIH Publ no. 95-1468.
3. Alexandru N, Jardin I, Popov D, Simionescu M, Garcia-Estan J, Salido GM, Rosado JA. Effect of homocysteine on calcium mobilisation and platelet function in type 2 diabetes mellitus. J Cell Mol Med. 2007;12:2015.
4. Sasaki N, Yamashita T, Takaya T, Shinohara M, Shiraki R, Takeda M, Emoto N, Fukatsu A, Hayashi T, Ikemoto K, Nomura T, Yokoyama M, Hirata K-I, Kawashima S. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus. Arterioscler Thromb Vasc Biol. 2008;28:1068–76.
5. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease. J Am Coll Cardiol. 2007;49:2112–9.